Roche receives blood cancer drug blow after Gazyva trial fails to meet endpoint | Online Medical Assistant Training Programs
Roche receives blood cancer drug blow after Gazyva trial fails to meet endpoint | Online Medical Assistant Training Programs
https://onlinemedicalassistantprogramsedu.wordpress.com/2016/07/18/roche-receives-blood-cancer-drug-blow-after-gazyva-trial-fails-to-meet-endpoint/
ZURICH (Reuters) – Swiss drugmaker Roche said trials showed its new blood cancer drug Gazyva failed to deliver significant improvements over an older medicine in people with an aggressive type of blood cancer, a blow in its fight against competition from biosimilars.
